Torsdag 1 Maj | 05:15:16 Europe / Stockholm

Prenumeration

2025-04-29 09:12:00

Redeye updates its view of Curasight following the Q1 report and recent events in the company, including the announced rights issue of DKK100m, which has been factored into our valuation and results in a lower valuation range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/